740 related articles for article (PubMed ID: 25110414)
1. Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years.
Panczyk M
World J Gastroenterol; 2014 Aug; 20(29):9775-827. PubMed ID: 25110414
[TBL] [Abstract][Full Text] [Related]
2. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.
Cecchin E; De Mattia E; Ecca F; Toffoli G
Drug Resist Updat; 2018 Jul; 39():18-40. PubMed ID: 30075835
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy.
De Mattia E; Cecchin E; Toffoli G
Drug Resist Updat; 2015 May; 20():39-70. PubMed ID: 26027741
[TBL] [Abstract][Full Text] [Related]
4. FOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapy.
Mohelnikova-Duchonova B; Melichar B; Soucek P
World J Gastroenterol; 2014 Aug; 20(30):10316-30. PubMed ID: 25132748
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics in colorectal cancer: the first step for individualized-therapy.
Bandrés E; Zárate R; Ramirez N; Abajo A; Bitarte N; Garíia-Foncillas J
World J Gastroenterol; 2007 Nov; 13(44):5888-901. PubMed ID: 17990354
[TBL] [Abstract][Full Text] [Related]
6. [Molecular biology in clinical cancer research: the example of digestive cancers].
Lièvre A; Laurent-Puig P
Rev Epidemiol Sante Publique; 2005 Jun; 53(3):267-82. PubMed ID: 16227914
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacogenomics of the first-line treatment for gastric cancer: advances in the identification of genomic biomarkers for clinical response to chemotherapy].
Castro-Rojas C; Ortiz-Lópezj R; Rojas-Martínez A
Invest Clin; 2014 Jun; 55(2):185-202. PubMed ID: 24974634
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
Stiegelbauer V; Perakis S; Deutsch A; Ling H; Gerger A; Pichler M
World J Gastroenterol; 2014 Sep; 20(33):11727-35. PubMed ID: 25206276
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics in chemotherapy of colorectal cancer.
Henriette Tanja L; Guchelaar HJ; Gelderblom H
Best Pract Res Clin Gastroenterol; 2009; 23(2):257-73. PubMed ID: 19414151
[TBL] [Abstract][Full Text] [Related]
10. [Recent developments of pharmacogenomics in the treatment of colorectal cancers].
Astier A
Ann Pharm Fr; 2010 Jul; 68(4):233-53. PubMed ID: 20637356
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
Bosch TM
Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of colorectal cancer.
Marsh S
Expert Opin Pharmacother; 2005 Dec; 6(15):2607-16. PubMed ID: 16316300
[TBL] [Abstract][Full Text] [Related]
13. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future.
Vodenkova S; Buchler T; Cervena K; Veskrnova V; Vodicka P; Vymetalkova V
Pharmacol Ther; 2020 Feb; 206():107447. PubMed ID: 31756363
[TBL] [Abstract][Full Text] [Related]
14. Novel therapeutics in metastatic colorectal cancer: molecular insights and pharmacogenomic implications.
Hanna DL; Lenz HJ
Expert Rev Clin Pharmacol; 2016 Aug; 9(8):1091-108. PubMed ID: 27031164
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics of colorectal cancer prevention and treatment.
Nguyen H; Tran A; Lipkin S; Fruehauf JP
Cancer Invest; 2006 Oct; 24(6):630-9. PubMed ID: 16982469
[TBL] [Abstract][Full Text] [Related]
16. Current trends in clinical genetics of colorectal cancer.
Markovic S; Dimitrijevic I; Zogovic B; Markovic V; Barisic G; Krivokapic Z
J BUON; 2016; 21(5):1042-1049. PubMed ID: 27837603
[TBL] [Abstract][Full Text] [Related]
17. Recent applications of chemosensitivity tests for colorectal cancer treatment.
Yoon YS; Kim JC
World J Gastroenterol; 2014 Nov; 20(44):16398-408. PubMed ID: 25469008
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics and -genetics in colorectal cancer.
Pohl A; Lurje G; Manegold PC; Lenz HJ
Adv Drug Deliv Rev; 2009 May; 61(5):375-80. PubMed ID: 19100300
[TBL] [Abstract][Full Text] [Related]
19. Molecular markers in the treatment of metastatic colorectal cancer.
Wilson PM; Labonte MJ; Lenz HJ
Cancer J; 2010; 16(3):262-72. PubMed ID: 20526105
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer: pharmacogenetics support for the correct drug prescription.
Olivera G; Sendra L; Herrero MJ; Puig C; Aliño SF
Pharmacogenomics; 2019 Jul; 20(10):741-763. PubMed ID: 31368847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]